Dr Carl-Magnus Larsson reappointed as CEO for a third term
The Governor-General has reappointed Dr Carl-Magnus Larsson as the CEO of ARPANSA for a term of three years, commencing on 22 March 2019.
This is Dr Larsson’s third term as CEO since he commenced at ARPANSA in March 2010.
Dr Larsson is energised about ARPANSA’s future, stating, ‘I am proud of what the organisation has achieved, and look forward to another three years.’
He says, ‘I look forward to continuing to ensure Australians are protected from the harmful effects of radiation – by maintaining the delivery of our high quality services, providing Australians with health advice and independently regulating Commonwealth entities that use or produce radiation.’
Dr Larsson highlights that, ‘ARPANSA plays many roles nationally and internationally and contributes to ensuring that Australians stay healthy and safe. Some of our great services include holding the primary standard for absorbed dose in Australia, monitoring UV radiation minute-by-minute, auditing radiotherapy equipment used in cancer treatment, and offering radiation monitoring services to Australians who work with radiation.’
Dr Larsson is a member of the International Atomic Energy Agency Commission on Safety Standards and was recently appointed Vice-President of the 8th review meeting under the terms of the Convention on Nuclear Safety. He is a member of the Main Commission of the International Commission on Radiological Protection and past chair of Committee 5. He has been the Australian Representative to the United Nations Scientific Committee on the Effects of Atomic Radiation and chaired the Committee 2012-2015.
Prior to working at ARPANSA, Dr Larsson worked at the Swedish Radiation Protection Authority holding positions as branch head and Deputy Director-General with responsibilities for radiation protection, waste management, radioactive materials, security and emergency preparedness and response.